Understanding the Mechanism: How Does Bexarotene Work?
•
3 min read
First approved by the FDA in 1999 for the treatment of cutaneous T-cell lymphoma (CTCL), bexarotene is a synthetic retinoid with a highly specific mechanism of action. It is considered a 'rexinoid' due to its ability to selectively bind to and activate retinoid X receptors (RXRs).
